INITIAL COMMENTS
|
This report is a result of an on-site inspection conducted for the approval to use a narcotic agent, specifically buprenorphine, in the residential detoxification from opioid dependence. This inspection was conducted on January 6, 2009 by staff from the Division of Drug and Alcohol Program Licensure. Based on the findings of the on-site inspection, Pyramid Healthcare, Inc. was found not to be in compliance with the applicable chapters of 28 PA Code which pertain to the facility. Deficiencies were identified during this inspection and plan of correction is due on February 9, 2009.
|
Plan of Correction
|
715.2(a)(b) LICENSURE Relationship of Federal and State Regulations
(a) A narcotic treatment program shall comply with Federal regulations and requirements governing the administration, dispensing and storage of agents.
(b) This chapter is intended to supplement the Federal regulations governing narcotic treatment programs in 21 CFR Chapter II, 1300-1399 (relating to Drug Enforcement Administration, Department of Justice).
|
Observations
Based on the review of the DEA registration, the facility failed to provide a DEA registration in the facility address.
The findings include:
DEA registrations were reviewed on January 6, 2009. The facility did not provide a DEA registration for this address.
|
Plan of Correction
We are currently pursing changing the DEA address to match the facility address. We will be submitting appropriate paperwork to achieve this goal. Completion date will be no later than 3/11/09. |